TNX-1900
TNX-OX-CM201
Phase 2 small_molecule completed
Quick answer
TNX-1900 for Chronic Migraine is a Phase 2 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Chronic Migraine
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed